2017
DOI: 10.1016/s0016-5085(17)31114-9
|View full text |Cite
|
Sign up to set email alerts
|

Intragastric Acid Suppression and Symptomatic Improvement in Patients with Erosive Gastroesophageal Reflux Disease (GERD). A Randomized Controlled Clinical Trial of 20 MGS of S-Pantroprazole (Levopantoprazole) Versus 40 MG of Racemic Pantoprazole Sodium

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles